NCT04954599 2025-10-07
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Maastricht University Medical Center
Phase 1/2 Recruiting
Clinical Trials
24 trialsNCT04258956 2025-09-11
AXAGIST
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Completed
NCT03186326 2025-06-29
SAMCO
Federation Francophone de Cancerologie Digestive
Phase 2 Completed
NCT03357757 2025-06-26
LATENT
AHS Cancer Control Alberta
Phase 2 Completed
NCT04513951 2025-01-09
AVETRIC
Gruppo Oncologico del Nord-Ovest
Phase 2 Completed
NCT05291156 2024-02-01
CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
University of Campania Luigi Vanvitelli
Phase 2 Unknown
NCT03783936 2023-12-19
Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas
Hoosier Cancer Research Network
Phase 2 Completed
NCT03854799 2023-10-19
AVANA
Gruppo Oncologico del Nord-Ovest
Phase 2 Completed
NCT05249569 2023-05-03
Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma
University of Texas Southwestern Medical Center
Phase 2 Terminated
NCT03299660 2023-03-16
Avelumab With Chemoradiation in Locally Advanced Rectal Cancer
Peter MacCallum Cancer Centre, Australia
Phase 2 Completed
NCT05429866 2023-03-08
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
Phase 2 Unknown
NCT03827044 2022-10-07
POLEM
Royal Marsden NHS Foundation Trust
Phase 3 Terminated
NCT03174405 2022-09-29
AVETUX
AIO-Studien-gGmbH
Phase 2 Completed
NCT04561336 2022-05-05
Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer
University of Campania Luigi Vanvitelli
Phase 2 Completed
NCT03800953 2021-09-08
The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital
Phase 2 Unknown
NCT03389126 2021-03-17
AvelumabHCC
Seoul National University Hospital
Phase 2 Completed
NCT03608046 2020-10-22
AVETUXIRI
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 2 Unknown
NCT03152565 2020-10-06
AVEVAC
Grupo Espanol Multidisciplinario del Cancer Digestivo
Phase 1/2 Completed
NCT03344172 2020-05-14
17-134
University of Pittsburgh
Phase 2 Terminated
NCT03150706 2020-04-03
Avelumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer
Asan Medical Center
Phase 2 Unknown
NCT03481920 2019-08-22
A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer
PH Research, S.L.
Phase EARLY_PHASE1 Terminated
NCT03944252 2019-07-26
CARACAS
Gruppo Oncologico del Nord-Ovest
Phase 2 Unknown
NCT03966118 2019-06-03
AIO-STO-0218
Charite University, Berlin, Germany
Phase 2 Unknown
NCT03812796 2019-02-05
EMERGE
Royal Marsden NHS Foundation Trust
Phase 2 Unknown